Methocarbamol

Product NDC: 31722-534
11-digit product format: 317220534
Labeler code: 31722
Product ID: 31722-534_bf48c1c6-3723-1fde-e053-2995a90af824
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Methocarbamol
Dosage form: TABLET
Route: ORAL
Labeler: Camber Pharmaceuticals, Inc.
Application: ANDA090200
Marketing category: ANDA
Marketing start: 2013-03-20
Substance: METHOCARBAMOL
Active strength: 750 mg/1
Pharmacologic classes: Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A090200-001	METHOCARBAMOL	METHOCARBAMOL	500MG	TABLET / ORAL	AA		2009-11-06
A090200-002	METHOCARBAMOL	METHOCARBAMOL	750MG	TABLET / ORAL	AA		2009-11-06

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A090200-001	AA
A090200-002	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A090200-001	METHOCARBAMOL	500MG	TABLET / ORAL	AA	2009-11-06	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A090200-002	METHOCARBAMOL	750MG	TABLET / ORAL	AA	2009-11-06	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A090200-001	AA	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090200-002	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090200-001	AA	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090200-002	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A090200-001	AA	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090200-002	AA	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090200-001	AA	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090200-002	AA	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090200-001	AA	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090200-002	AA	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090200-001	AA	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090200-002	AA	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090200-001	AA	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090200-002	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090200-001	AA	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090200-002	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090200-001	AA	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090200-002	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A090200-001	AA	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A090200-002	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090200-001	AA	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090200-002	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090200-001	AA	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090200-002	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090200-001	AA	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A090200-002	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A090200-001	AA	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A090200-002	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090200-001	AA	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A090200-002	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A090200-001	AA	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A090200-002	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A090200-001	AA	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A090200-002	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A090200-001	AA	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090200-002	AA	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A090200-001	AA	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A090200-002	AA	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A090200-001	AA	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A090200-002	AA	1	`782e0a99824c…`

Additional Listing Data#

Finished product: Yes
Brand name base: Methocarbamol
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
METHOCARBAMOL	750 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
125OD7737X	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
197943	Internal RxNorm lookup
197944	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
43af0c41-9990-4902-9384-75de5ea08283	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
492965be-47bc-38cf-57c4-5c5e0343abe5	Product name	6	20211028
02a01e9c-3f4e-c0ee-6542-be865127aea3	Product name	8	20190205

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
31722-534-01	Methocarbamol	100 in 1 BOTTLE	TABLET	100	5
31722-534-01	Methocarbamol	12 in 1 CASE	TABLET	12	5
31722-534-05	Methocarbamol	500 in 1 BOTTLE	TABLET	500	5
31722-534-05	Methocarbamol	12 in 1 CASE	TABLET	12	5
31722-534-30	Methocarbamol	30 in 1 BOTTLE	TABLET	30	5
31722-534-30	Methocarbamol	12 in 1 CASE	TABLET	12	5
31722-534-60	Methocarbamol	60 in 1 BOTTLE	TABLET	60	5
31722-534-60	Methocarbamol	12 in 1 CASE	TABLET	12	5

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
31722-534-01	EA - Each	31722-534	1e316a97-b5be-4660-9bce-2534cec2f845	1	2012-07-24
31722-534-05	EA - Each	31722-534	2bdfd8a0-8c5c-4fb6-8289-604c56329e79	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
METHOCARBAMOL	ACTIVE INGREDIENT	125OD7737X	METHOCARBAMOL TABLET [PROFICIENT RX LP]	4
METHOCARBAMOL	ACTIVE MOIETY	125OD7737X	METHOCARBAMOL TABLET [PROFICIENT RX LP]	4
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	METHOCARBAMOL TABLET [PROFICIENT RX LP]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	METHOCARBAMOL TABLET [PROFICIENT RX LP]	4
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	METHOCARBAMOL TABLET [PROFICIENT RX LP]	4
POVIDONE K90	INACTIVE INGREDIENT	RDH86HJV5Z	METHOCARBAMOL TABLET [PROFICIENT RX LP]	4
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	METHOCARBAMOL TABLET [PROFICIENT RX LP]	4
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	METHOCARBAMOL TABLET [PROFICIENT RX LP]	4
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	METHOCARBAMOL TABLET [PROFICIENT RX LP]	4
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	METHOCARBAMOL TABLET [PROFICIENT RX LP]	4
METHOCARBAMOL	ACTIVE INGREDIENT	125OD7737X	METHOCARBAMOL TABLET [CAMBER PHARMACEUTICALS, INC.]	3
METHOCARBAMOL	ACTIVE MOIETY	125OD7737X	METHOCARBAMOL TABLET [CAMBER PHARMACEUTICALS, INC.]	3
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	METHOCARBAMOL TABLET [CAMBER PHARMACEUTICALS, INC.]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	METHOCARBAMOL TABLET [CAMBER PHARMACEUTICALS, INC.]	3
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	METHOCARBAMOL TABLET [CAMBER PHARMACEUTICALS, INC.]	3
POVIDONE K90	INACTIVE INGREDIENT	RDH86HJV5Z	METHOCARBAMOL TABLET [CAMBER PHARMACEUTICALS, INC.]	3
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	METHOCARBAMOL TABLET [CAMBER PHARMACEUTICALS, INC.]	3
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	METHOCARBAMOL TABLET [CAMBER PHARMACEUTICALS, INC.]	3
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	METHOCARBAMOL TABLET [CAMBER PHARMACEUTICALS, INC.]	3
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	METHOCARBAMOL TABLET [CAMBER PHARMACEUTICALS, INC.]	3
METHOCARBAMOL	ACTIVE INGREDIENT	125OD7737X	METHOCARBAMOL TABLET [BLENHEIM PHARMACAL, INC.]	2
METHOCARBAMOL	ACTIVE INGREDIENT	125OD7737X	METHOCARBAMOL TABLET [AMERICAN HEALTH PACKAGING]	2
METHOCARBAMOL	ACTIVE MOIETY	125OD7737X	METHOCARBAMOL TABLET [BLENHEIM PHARMACAL, INC.]	2
METHOCARBAMOL	ACTIVE MOIETY	125OD7737X	METHOCARBAMOL TABLET [AMERICAN HEALTH PACKAGING]	2
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	METHOCARBAMOL TABLET [BLENHEIM PHARMACAL, INC.]	2
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	METHOCARBAMOL TABLET [AMERICAN HEALTH PACKAGING]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	METHOCARBAMOL TABLET [BLENHEIM PHARMACAL, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	METHOCARBAMOL TABLET [AMERICAN HEALTH PACKAGING]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	METHOCARBAMOL TABLET [BLENHEIM PHARMACAL, INC.]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	METHOCARBAMOL TABLET [AMERICAN HEALTH PACKAGING]	2
POVIDONE K90	INACTIVE INGREDIENT	RDH86HJV5Z	METHOCARBAMOL TABLET [BLENHEIM PHARMACAL, INC.]	2
POVIDONE K90	INACTIVE INGREDIENT	RDH86HJV5Z	METHOCARBAMOL TABLET [AMERICAN HEALTH PACKAGING]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	METHOCARBAMOL TABLET [BLENHEIM PHARMACAL, INC.]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	METHOCARBAMOL TABLET [AMERICAN HEALTH PACKAGING]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	METHOCARBAMOL TABLET [BLENHEIM PHARMACAL, INC.]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	METHOCARBAMOL TABLET [AMERICAN HEALTH PACKAGING]	2
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	METHOCARBAMOL TABLET [BLENHEIM PHARMACAL, INC.]	2
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	METHOCARBAMOL TABLET [AMERICAN HEALTH PACKAGING]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	METHOCARBAMOL TABLET [AMERICAN HEALTH PACKAGING]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	METHOCARBAMOL TABLET [BLENHEIM PHARMACAL, INC.]	2
METHOCARBAMOL	ACTIVE INGREDIENT	125OD7737X	METHOCARBAMOL TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
METHOCARBAMOL	ACTIVE INGREDIENT	125OD7737X	METHOCARBAMOL TABLET [CONTRACT PHARMACY SERVICES-PA]	1
METHOCARBAMOL	ACTIVE INGREDIENT	125OD7737X	METHOCARBAMOL TABLET [KAISER FOUNDATION HOSPITALS]	1
METHOCARBAMOL	ACTIVE INGREDIENT	125OD7737X	METHOCARBAMOL TABLET [REBEL DISTRIBUTORS CORP]	1
METHOCARBAMOL	ACTIVE MOIETY	125OD7737X	METHOCARBAMOL TABLET [REBEL DISTRIBUTORS CORP]	1
METHOCARBAMOL	ACTIVE MOIETY	125OD7737X	METHOCARBAMOL TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
METHOCARBAMOL	ACTIVE MOIETY	125OD7737X	METHOCARBAMOL TABLET [KAISER FOUNDATION HOSPITALS]	1
METHOCARBAMOL	ACTIVE MOIETY	125OD7737X	METHOCARBAMOL TABLET [CONTRACT PHARMACY SERVICES-PA]	1
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	METHOCARBAMOL TABLET [KAISER FOUNDATION HOSPITALS]	1
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	METHOCARBAMOL TABLET [REBEL DISTRIBUTORS CORP]	1
HYDROXYPROPYL CELLULOSE	INACTIVE INGREDIENT	RFW2ET671P	METHOCARBAMOL TABLET [CONTRACT PHARMACY SERVICES-PA]	1
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	METHOCARBAMOL TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	METHOCARBAMOL TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	METHOCARBAMOL TABLET [KAISER FOUNDATION HOSPITALS]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	METHOCARBAMOL TABLET [REBEL DISTRIBUTORS CORP]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	METHOCARBAMOL TABLET [CONTRACT PHARMACY SERVICES-PA]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	METHOCARBAMOL TABLET [CONTRACT PHARMACY SERVICES-PA]	1
POLYETHYLENE GLYCOL	INACTIVE INGREDIENT	3WJQ0SDW1A	METHOCARBAMOL TABLET [KAISER FOUNDATION HOSPITALS]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	METHOCARBAMOL TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	METHOCARBAMOL TABLET [REBEL DISTRIBUTORS CORP]	1
POVIDONE K90	INACTIVE INGREDIENT	RDH86HJV5Z	METHOCARBAMOL TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
POVIDONE K90	INACTIVE INGREDIENT	RDH86HJV5Z	METHOCARBAMOL TABLET [CONTRACT PHARMACY SERVICES-PA]	1
POVIDONE K90	INACTIVE INGREDIENT	RDH86HJV5Z	METHOCARBAMOL TABLET [KAISER FOUNDATION HOSPITALS]	1
POVIDONE K90	INACTIVE INGREDIENT	RDH86HJV5Z	METHOCARBAMOL TABLET [REBEL DISTRIBUTORS CORP]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	METHOCARBAMOL TABLET [REBEL DISTRIBUTORS CORP]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	METHOCARBAMOL TABLET [KAISER FOUNDATION HOSPITALS]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	METHOCARBAMOL TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	METHOCARBAMOL TABLET [CONTRACT PHARMACY SERVICES-PA]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	METHOCARBAMOL TABLET [CONTRACT PHARMACY SERVICES-PA]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	METHOCARBAMOL TABLET [REBEL DISTRIBUTORS CORP]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	METHOCARBAMOL TABLET [KAISER FOUNDATION HOSPITALS]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	METHOCARBAMOL TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	METHOCARBAMOL TABLET [REBEL DISTRIBUTORS CORP]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	METHOCARBAMOL TABLET [CONTRACT PHARMACY SERVICES-PA]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	METHOCARBAMOL TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	METHOCARBAMOL TABLET [KAISER FOUNDATION HOSPITALS]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	METHOCARBAMOL TABLET [CONTRACT PHARMACY SERVICES-PA]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	METHOCARBAMOL TABLET [PREFERRED PHARMACEUTICALS, INC.]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	METHOCARBAMOL TABLET [REBEL DISTRIBUTORS CORP]	1
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	METHOCARBAMOL TABLET [KAISER FOUNDATION HOSPITALS]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
31722-534	METHOCARBAMOL (METHOCARBAMOL) TABLET [CAMBER PHARMACEUTICALS, INC.]	5	Current NDC, Legacy NDC, 8 package rows	20210527_43af0c41-9990-4902-9384-75de5ea08283.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 23 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Methocarbamol	METHOCARBAMOL	American Health Packaging	d842fe4e-fc46-4d70-9ca3-b47191672f96	2026-07-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Unit Dose Solutions, Inc.	5539d4f6-1192-2770-e063-6394a90a1e50	2026-06-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
METHOCARBAMOL	METHOCARBAMOL	DIRECT RX	31508051-c9cb-149b-e054-00144ff88e88	2026-01-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	AvPAK	be37bc85-6a41-00d8-e053-2a95a90ae504	2026-01-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Northwind Health Company, LLC	f31ccb09-7a9a-60af-e053-2995a90a6e97	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Northwind Health Company, LLC	df63611f-90e4-6bbe-e053-2a95a90a2aad	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Aphena Pharma Solutions - Tennessee, LLC	18810520-3040-4802-e063-6294a90a1ec0	2025-12-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Cardinal Health 107, LLC	05b287d3-5004-4d8b-9ebe-a96caa2b8d89	2025-11-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	A-S Medication Solutions	9aed8304-fa4e-49d6-bd81-fcb3e4cc6173	2025-10-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	A-S Medication Solutions	ff55df39-e314-4120-8fab-3757cbe5a872	2025-10-16	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	A-S Medication Solutions	069045f1-d699-41d0-b674-cdb71cd5fbd0	2025-10-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Preferred Pharmaceuticals Inc.	eed9ebd1-c243-4e82-bf4e-5fec370e722e	2025-02-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Coupler LLC	2cee3893-70b7-6c2c-e063-6394a90aa79a	2025-01-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Advanced Rx Pharmacy of Tennessee, LLC	f4e98f9f-b20b-8608-e053-2a95a90aa6b0	2024-12-31	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Bryant Ranch Prepack	3f47c39b-9373-454f-9a4e-ba6dd65dd7a4	2024-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Bryant Ranch Prepack	add9e47f-11ac-e10d-bfc2-b9c52aa08fa5	2024-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	NuCare Pharmaceuticals,Inc.	9d6024b2-ee1a-3a79-e053-2a95a90a1bf4	2024-08-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	NuCare Pharmaceuticals, Inc.	3e89a426-c741-2f44-e054-00144ff8d46c	2024-08-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	Aphena Pharma Solutions - Tennessee, LLC	1880efb2-b97e-1e4d-e063-6294a90ab3e3	2024-05-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200
Methocarbamol	METHOCARBAMOL	XLCare Pharmaceuticals Inc.	f8bfb5cb-b7d0-4e09-b6bd-97a51d82c991	2024-02-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 090200 application number: ANDA090200

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
125OD7737X	METHOCARBAMOL	532-03-6	METHOCARBAMOL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197943	methocarbamol 500 MG Oral Tablet	PSN	ff55df39-e314-4120-8fab-3757cbe5a872	22
197944	methocarbamol 750 MG Oral Tablet	PSN	ff55df39-e314-4120-8fab-3757cbe5a872	22
197943	methocarbamol 500 MG Oral Tablet	SCD	ff55df39-e314-4120-8fab-3757cbe5a872	22
197944	methocarbamol 750 MG Oral Tablet	SCD	ff55df39-e314-4120-8fab-3757cbe5a872	22
197944	methocarbamol 750 MG Oral Tablet	PSN	2c1f5949-d771-45c6-8d8a-5e1942c853dc	14
197944	methocarbamol 750 MG Oral Tablet	SCD	2c1f5949-d771-45c6-8d8a-5e1942c853dc	14
197943	methocarbamol 500 MG Oral Tablet	PSN	10ae354f-94a4-4d4e-bccc-ea189726b7ce	9
197944	methocarbamol 750 MG Oral Tablet	PSN	10ae354f-94a4-4d4e-bccc-ea189726b7ce	9
197943	methocarbamol 500 MG Oral Tablet	SCD	10ae354f-94a4-4d4e-bccc-ea189726b7ce	9
197944	methocarbamol 750 MG Oral Tablet	SCD	10ae354f-94a4-4d4e-bccc-ea189726b7ce	9
197944	methocarbamol 750 MG Oral Tablet	PSN	82d61d90-dd98-4fbd-8bdf-77fed14be30e	7
197944	methocarbamol 750 MG Oral Tablet	PSN	3f47c39b-9373-454f-9a4e-ba6dd65dd7a4	7
197944	methocarbamol 750 MG Oral Tablet	SCD	82d61d90-dd98-4fbd-8bdf-77fed14be30e	7
197944	methocarbamol 750 MG Oral Tablet	SCD	3f47c39b-9373-454f-9a4e-ba6dd65dd7a4	7
197943	methocarbamol 500 MG Oral Tablet	PSN	43af0c41-9990-4902-9384-75de5ea08283	5
197943	methocarbamol 500 MG Oral Tablet	PSN	be37bc85-6a41-00d8-e053-2a95a90ae504	5
197944	methocarbamol 750 MG Oral Tablet	PSN	4e3d52bb-cd03-550c-e054-00144ff88e88	5
197944	methocarbamol 750 MG Oral Tablet	PSN	be37bc85-6a41-00d8-e053-2a95a90ae504	5
197944	methocarbamol 750 MG Oral Tablet	PSN	43af0c41-9990-4902-9384-75de5ea08283	5
197944	methocarbamol 750 MG Oral Tablet	PSN	26a25c66-3dc4-4cfa-bd9f-ef3fa068364a	5
197943	methocarbamol 500 MG Oral Tablet	SCD	be37bc85-6a41-00d8-e053-2a95a90ae504	5
197943	methocarbamol 500 MG Oral Tablet	SCD	43af0c41-9990-4902-9384-75de5ea08283	5
197944	methocarbamol 750 MG Oral Tablet	SCD	43af0c41-9990-4902-9384-75de5ea08283	5
197944	methocarbamol 750 MG Oral Tablet	SCD	be37bc85-6a41-00d8-e053-2a95a90ae504	5
197944	methocarbamol 750 MG Oral Tablet	SCD	4e3d52bb-cd03-550c-e054-00144ff88e88	5
197944	methocarbamol 750 MG Oral Tablet	SCD	26a25c66-3dc4-4cfa-bd9f-ef3fa068364a	5
197943	methocarbamol 500 MG Oral Tablet	PSN	c54e8984-3655-4f09-ac2f-e6ea4c394121	4
197943	methocarbamol 500 MG Oral Tablet	PSN	270b68a6-1469-190d-e054-00144ff8d46c	4
197943	methocarbamol 500 MG Oral Tablet	PSN	d842fe4e-fc46-4d70-9ca3-b47191672f96	4
197944	methocarbamol 750 MG Oral Tablet	PSN	c54e8984-3655-4f09-ac2f-e6ea4c394121	4
197944	methocarbamol 750 MG Oral Tablet	PSN	3e89a426-c741-2f44-e054-00144ff8d46c	4
197944	methocarbamol 750 MG Oral Tablet	PSN	9145aa4c-48f8-de34-e053-2995a90a6a3c	4
197944	methocarbamol 750 MG Oral Tablet	PSN	d842fe4e-fc46-4d70-9ca3-b47191672f96	4
197944	methocarbamol 750 MG Oral Tablet	PSN	270b68a6-1469-190d-e054-00144ff8d46c	4
197943	methocarbamol 500 MG Oral Tablet	SCD	c54e8984-3655-4f09-ac2f-e6ea4c394121	4
197943	methocarbamol 500 MG Oral Tablet	SCD	d842fe4e-fc46-4d70-9ca3-b47191672f96	4
197943	methocarbamol 500 MG Oral Tablet	SCD	270b68a6-1469-190d-e054-00144ff8d46c	4
197944	methocarbamol 750 MG Oral Tablet	SCD	c54e8984-3655-4f09-ac2f-e6ea4c394121	4
197944	methocarbamol 750 MG Oral Tablet	SCD	d842fe4e-fc46-4d70-9ca3-b47191672f96	4
197944	methocarbamol 750 MG Oral Tablet	SCD	9145aa4c-48f8-de34-e053-2995a90a6a3c	4
197944	methocarbamol 750 MG Oral Tablet	SCD	270b68a6-1469-190d-e054-00144ff8d46c	4
197944	methocarbamol 750 MG Oral Tablet	SCD	3e89a426-c741-2f44-e054-00144ff8d46c	4
197944	methocarbamol 750 MG Oral Tablet	PSN	9d6024b2-ee1a-3a79-e053-2a95a90a1bf4	3
197944	methocarbamol 750 MG Oral Tablet	SCD	9d6024b2-ee1a-3a79-e053-2a95a90a1bf4	3
197944	methocarbamol 750 MG Oral Tablet	PSN	bc1bbd85-3f82-5d67-e053-2995a90a5781	2
197944	methocarbamol 750 MG Oral Tablet	PSN	df63611f-90e4-6bbe-e053-2a95a90a2aad	2
197944	methocarbamol 750 MG Oral Tablet	PSN	396ddbcd-82cb-4ac1-b80d-a00b290ccd0f	2
197944	methocarbamol 750 MG Oral Tablet	PSN	0fcc4b5e-c915-73c7-e054-00144ff88e88	2
197944	methocarbamol 750 MG Oral Tablet	SCD	df63611f-90e4-6bbe-e053-2a95a90a2aad	2
197944	methocarbamol 750 MG Oral Tablet	SCD	396ddbcd-82cb-4ac1-b80d-a00b290ccd0f	2
197944	methocarbamol 750 MG Oral Tablet	SCD	0fcc4b5e-c915-73c7-e054-00144ff88e88	2
197944	methocarbamol 750 MG Oral Tablet	SCD	bc1bbd85-3f82-5d67-e053-2995a90a5781	2
197943	methocarbamol 500 MG Oral Tablet	PSN	0defd325-d763-481e-afe8-86075e3c7e79	1
197944	methocarbamol 750 MG Oral Tablet	PSN	911efaf9-3814-a899-e053-2a95a90a174a	1
197944	methocarbamol 750 MG Oral Tablet	PSN	2cee3893-70b7-6c2c-e063-6394a90aa79a	1
197944	methocarbamol 750 MG Oral Tablet	PSN	0defd325-d763-481e-afe8-86075e3c7e79	1
197943	methocarbamol 500 MG Oral Tablet	SCD	0defd325-d763-481e-afe8-86075e3c7e79	1
197944	methocarbamol 750 MG Oral Tablet	SCD	911efaf9-3814-a899-e053-2a95a90a174a	1
197944	methocarbamol 750 MG Oral Tablet	SCD	0defd325-d763-481e-afe8-86075e3c7e79	1
197944	methocarbamol 750 MG Oral Tablet	SCD	2cee3893-70b7-6c2c-e063-6394a90aa79a	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
31722-534-01	31722053401	12 BOTTLE in 1 CASE (31722-534-01) / 100 TABLET in 1 BOTTLE	12 bottle	2013-03-20	0000-00-00	No	No	Current
31722-534-05	31722053405	12 BOTTLE in 1 CASE (31722-534-05) / 500 TABLET in 1 BOTTLE	12 bottle	2013-03-20	0000-00-00	No	No	Current
31722-534-30	31722053430	12 BOTTLE in 1 CASE (31722-534-30) / 30 TABLET in 1 BOTTLE	12 bottle	2013-03-20	0000-00-00	No	No	Current
31722-534-60	31722053460	12 BOTTLE in 1 CASE (31722-534-60) / 60 TABLET in 1 BOTTLE	12 bottle	2013-03-20	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Methocarbamol Tablets USP 8455901/0320 Rx only	American Health Packaging	2026-07-30	HUMAN PRESCRIPTION DRUG LABEL	6
Methocarbamol Tablets USP Rx Only	AvPAK	2026-01-08	HUMAN PRESCRIPTION DRUG LABEL	5
Methocarbamol Tablets USP Rx Only	Northwind Health Company, LLC	2026-01-01	HUMAN PRESCRIPTION DRUG LABEL	2
Methocarbamol Tablets USP Rx Only	A-S Medication Solutions	2025-10-16	HUMAN PRESCRIPTION DRUG LABEL	22
Methocarbamol Tablets USP Rx Only	Coupler LLC	2025-01-30	HUMAN PRESCRIPTION DRUG LABEL	1
Methocarbamol Tablets USP Rx Only	Bryant Ranch Prepack	2024-08-20	HUMAN PRESCRIPTION DRUG LABEL	7
Methocarbamol Tablets USP Rx Only	NuCare Pharmaceuticals,Inc.	2024-08-14	HUMAN PRESCRIPTION DRUG LABEL	3
Methocarbamol Tablets USP Rx Only	NuCare Pharmaceuticals, Inc.	2024-08-13	HUMAN PRESCRIPTION DRUG LABEL	4
Methocarbamol - RedPharm Drug, Inc.	RedPharm Drug, Inc.	2024-07-11	HUMAN PRESCRIPTION DRUG LABEL	5
Methocarbamol Tablets USP Rx Only	REMEDYREPACK INC.	2024-02-21	HUMAN PRESCRIPTION DRUG LABEL	10
Methocarbamol Tablets USP Rx Only	A-S Medication Solutions	2024-01-05	HUMAN PRESCRIPTION DRUG LABEL	14
Methocarbamol Tablets USP Rx Only	RPK Pharmaceuticals, Inc.	2023-06-07	HUMAN PRESCRIPTION DRUG LABEL	5
METHOCARBAMOL	Direct_Rx	2023-06-06	HUMAN PRESCRIPTION DRUG LABEL	4
Methocarbamol Tablets USP Rx Only	Quality Care Products LLC	2022-11-28	Human Prescription Drug Label	6
Methocarbamol Tablets USP Rx Only	Proficient Rx LP	2022-10-01	HUMAN PRESCRIPTION DRUG LABEL	9
Methocarbamol Tablets USP Rx Only	REMEDYREPACK INC.	2022-07-13	HUMAN PRESCRIPTION DRUG LABEL	6
Methocarbamol Tablets USP Rx Only	Preferred Pharmaceuticals, Inc.	2021-07-21	HUMAN PRESCRIPTION DRUG LABEL	6
Methocarbamol Tablets USP Rx Only	A-S Medication Solutions	2021-06-16	HUMAN PRESCRIPTION DRUG LABEL	7
Methocarbamol Tablets USP Rx Only	Camber Pharmaceuticals, Inc. \| Hetero Labs Limited Unit III	2021-04-06	HUMAN PRESCRIPTION DRUG LABEL	5
METHOCARBAMOL - Central Packaging \| Central Packaging, LLC	Central Packaging \| Central Packaging, LLC	2021-02-26	HUMAN PRESCRIPTION DRUG LABEL	2
Methocarbamol Tablets USP Rx Only	St. Mary's Medical Park Pharmacy \| St. Mary/'s Medical Park Pharmacy	2020-12-02	HUMAN PRESCRIPTION DRUG LABEL	6